MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, K.

Mechanisms influencing stimulatory effects of spermine at recombinant N- methyl-D-aspartate receptors

K Williams

Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104-6084.

Stimulatory effects of spermine at heteromeric N-methyl-D-aspartate (NMDA) receptors expressed from cloned subunits were studied by voltage- clamp recording in Xenopus oocytes. At NR1A/NR2B receptors, in the presence of a saturating concentration of glycine, the magnitude of spermine stimulation was dependent on the concentration of NMDA or glutamate. In oocytes voltage-clamped at -25 mV, spermine markedly enhanced the response to 10 microM NMDA but had little or no effect on the response to 10 microM NMDA. This effect was not related to the size of the macroscopic currents, the quantity or ratio of injected receptor subunit RNAs, or a voltage-dependent block by spermine. Spermine induced a small (1.2-1.5-fold) decrease in the affinity of NR1A/NR2B receptors for NMDA and glutamate. This decrease was sufficient to counteract the stimulatory effect of spermine at low concentrations of NMDA and glutamate, resulting in no net effect of spermine or a decrease in macroscopic currents in the presence of spermine with low concentrations of agonist. Spermine did not alter the affinity of NR1A/NR2A receptors for NMDA. Endogenous polyamines could act as a bidirectional gain control at some native NMDA receptors containing the NR1A and NR2B subunits, by dampening the response to low concentrations of glutamate and enhancing the response to high concentrations of glutamate. Alternatively, polyamines could enhance the decay of NMDA receptor-mediated responses by increasing the rate of dissociation of glutamate from the receptor.

Volume 46, Issue 1, pp. 161-168, 07/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
L. Jin, M. Miyazaki, S. Mizuno, M. Takigawa, T. Hirose, K. Nishimura, T. Toida, K. Williams, K. Kashiwagi, and K. Igarashi
The Pore Region of N-Methyl-D-aspartate Receptors Differentially Influences Stimulation and Block by Spermine
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 68 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Kashiwagi, I. Tanaka, M. Tamura, H. Sugiyama, T. Okawara, M. Otsuka, T. N. Sabado, K. Williams, and K. Igarashi
Anthraquinone Polyamines: Novel Channel Blockers to Study N-Methyl-D-Aspartate Receptors
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 884 - 893.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. D. Mott, M. S. Washburn, S. Zhang, and R. J. Dingledine
Subunit-Dependent Modulation of Kainate Receptors by Extracellular Protons and Polyamines
J. Neurosci., February 15, 2003; 23(4): 1179 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. D. Donevan and R. T. McCabe
Conantokin G Is an NR2B-Selective Competitive Antagonist of N-Methyl-D-aspartate Receptors
Mol. Pharmacol., September 1, 2000; 58(3): 614 - 623.
[Abstract] [Full Text]


Home page
J. Neurophysiol.Home page
G. Rumbaugh, K. Prybylowski, J. F. Wang, and S. Vicini
Exon 5 and Spermine Regulate Deactivation of NMDA Receptor Subtypes
J Neurophysiol, March 1, 2000; 83(3): 1300 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Masuko, K. Kashiwagi, T. Kuno, N. D. Nguyen, A. J. Pahk, J.-i. Fukuchi, K. Igarashi, and K. Williams
A Regulatory Domain (R1-R2) in the Amino Terminus of the N-Methyl-D-Aspartate Receptor: Effects of Spermine, Protons, and Ifenprodil, and Structural Similarity to Bacterial Leucine/Isoleucine/Valine Binding Protein
Mol. Pharmacol., June 1, 1999; 55(6): 957 - 969.
[Abstract] [Full Text]


Home page
Pharmacol. Rev.Home page
W. Danysz and C. G. Parsons
Glycine and N-Methyl-D-Aspartate Receptors: Physiological Significance and Possible Therapeutic Applications
Pharmacol. Rev., December 1, 1998; 50(4): 597 - 664.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. Williams, A. J. Pahk, K. Kashiwagi, T. Masuko, N. D. Nguyen, and K. Igarashi
The Selectivity Filter of the N-Methyl-D-Aspartate Receptor: A Tryptophan Residue Controls Block and Permeation of Mg2+
Mol. Pharmacol., May 1, 1998; 53(5): 933 - 941.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. Kashiwagi, A. J. Pahk, T. Masuko, K. Igarashi, and K. Williams
Block and Modulation of N-Methyl-D-Aspartate Receptors by Polyamines and Protons: Role of Amino Acid Residues in the Transmembrane and Pore-Forming Regions of NR1 and NR2 Subunits
Mol. Pharmacol., October 1, 1997; 52(4): 701 - 713.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
I. A. Omelchenko, C. S. Nelson, and C. N. Allen
Lead Inhibition of N-Methyl-D-aspartate Receptors Containing NR2A, NR2C and NR2D Subunits
J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1458 - 1464.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Chao, N. Seiler, J. Renault, K. Kashiwagi, T. Masuko, K. Igarashi, and K. Williams
N1-Dansyl-Spermine and N1-(n-Octanesulfonyl)-Spermine, Novel Glutamate Receptor Antagonists: Block and Permeation of N-Methyl-D-Aspartate Receptors
Mol. Pharmacol., May 1, 1997; 51(5): 861 - 871.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. L. Coughenour and J. J. Cordon
Characterization of Haloperidol and Trifluperidol as Subtype-Selective N-Methyl-D-Aspartate (NMDA) Receptor Antagonists Using [3H]TCP and [3H]Ifenprodil Binding in Rat Brain Membranes
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 584 - 592.
[Abstract] [Full Text]


Home page
ScienceHome page
S. Traynelis, M Hartley, and S. Heinemann
Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines
Science, May 12, 1995; 268(5212): 873 - 876.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics